Erythroblastaemia in natalizumab-treated patients with multiple sclerosis

Multiple Sclerosis and Related Disorders(2015)

引用 5|浏览16
暂无评分
摘要
•Early papers on the use of natalizumab in RRMS patients reported erythroblastemia as occasional.•Our data show that erythroblastaemia is more frequent on natalizumab than other treatments.•The clinical significance is unknown.
更多
查看译文
关键词
Multiple sclerosis,Natalizumab,Erythroblasts
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要